$202 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$10.8 BillionTotal revenue in the last quarter.
$3 BillionNet income is all revenues minus all expenses including taxes and interest in the last quarter.
$4.54Earnings per share is the amount of net income that is attributed to each single share outstanding.
$2.44 (3.06%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
17.58xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$3.25 BillionEarnings before interest expenses and taxes in the last quarter.
71,000The number of full time employees.
Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species, which it sells to veterinarians, distributors, and animal producers. The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients. The Alliances segment includes results from the Company's relationship with AstraZeneca LP related to sales of Nexium and Prilosec. The company was founded in 1891 and is headquartered in Kenilworth, NJ.
The global Flutamide (CAS 13311-84-7) market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strategies, market dynamics, and regio...OpenPR, 4 days ago
Summary List Placement Warren Buffett's Berkshire Hathaway surprised many followers by plowing more than $5 billion into pharmaceutical stocks, selling its Costco stake , and slashing bank holdings...Business Insider, 6 days ago
(Merck) 26 Nov 2020 | Darmstadt, Germany Collaboration is to advance modular production in industry In the future, it will be possible to meet customer and marketCompanyNewsHQ, 7 days ago